Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, and Cancer Genomics and Diagnostics.
LBA80 Regorafenib plus nivolumab vs investigator’s choice of chemotherapy in previously treated gastric or gastroesophageal cancer: INTEGRATE IIb, a randomized phase 3 AGITG Intergroup [NHMRC-CTC/IKF/AIO, ACCRU, TCOG/NHRI] study
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
Cancer multidisciplinary team meetings in practice: Results from a multi‐institutional quantitative survey and implications for policy change
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma
Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study